Ignite Creation Date:
2024-05-06 @ 3:19 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02254369
Status:
COMPLETED
Last Update Posted:
2015-02-18
First Post:
2014-09-29
Brief Title:
Safety Tolerability and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects
Sponsor:
GliaCure Inc
Organization:
GliaCure Inc
Study Overview
Official Title:
A Randomized Phase 1 Double-Blind Placebo-Controlled First-in-Human Safety Tolerability and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2015-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of the study is to assess the safety and tolerability of single oral doses of GC021109 when administered to healthy adult subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None